AZN

Q: What is the price of AstraZeneca (AZN) today?

The price of AstraZeneca (AZN) today is US$ 84,53, with a variation of 12.31% compared to the last year. The price of AstraZeneca (AZN) started the year trading around US$ 65,52 and today it is at US$ 84,53. Follow the real-time price chart, the historical price of AstraZeneca (AZN), and stock data from Ibovespa and international markets.

Q: When does AstraZeneca (AZN) pay dividends?

AstraZeneca (AZN) distributed dividends in the last year,in the months of March and September totaling US$ 1,57. The Dividend Yield for the last 12 months is 1,83%.

Q: AstraZeneca (AZN) is it worth it?

Currently, AstraZeneca (AZN) is priced at US$ 84,53, with a P/E of 28,39%, representing a deviation of 13,23% from its historical average P/E. In the last year, the stock showed a variation of 12.31% in its price and distributed US$ 1,57 in dividends, resulting in a Dividend Yield of 1,83%. The total shareholder return was 12,31%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of AstraZeneca (AZN)?

Investing in stocks of AstraZeneca (AZN) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of AstraZeneca (AZN) yield today?

The yield of AstraZeneca (AZN) was 4,60% in the last month, 12,31% in the last year and 71,62% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 1,57 in dividends, um Dividend Yield de 1,83%.If you wanted to buy 100 stocks of AstraZeneca (AZN) today, the total investment would be US$ 8.453,00, based on the current price of US$ 84,53.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 9.493,56In 5 years: US$ 14.507,04In 10 years: 31.018,28It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AstraZeneca PLC

Price

US$ 84,53

variation (12m)

12,31%

p/l

28,39

p/vp

5,90

DIVIDEND YIELD

1,83%

price AZN

BVMF

AZN

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of AZN

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

4,60%

3 months

19,67%

1 year

12,31%

2 years

29,52%

5 years

71,62%

10 years

266,95%

real profitability

profitability minus inflation.

1 month

4,60%

3 months

19,23%

1 year

7,38%

2 years

18,22%

5 years

26,82%

10 years

119,70%

Indicators AZN

check out the fundamentals of AstraZeneca shares

P/E

28,39

Sector: -3,47 Industry: -3,47

P/SALES RATIO (PSR)

4,61

Sector: -4,23 Industry: -4,23

P/BV

5,90

Sector: 1,89 Industry: 1,89

DIVIDEND YIELD (DY)

1,83%

Sector: - Industry: -

ROA

8,29%

Sector: -63,87% Industry: -63,87%

ROE

20,79%

Sector: -70,87% Industry: -70,87%

ROIC

12,44%

Sector: -2.084,36% Industry: -2.084,36%

NET MARGIN

16,23%

Sector: -41,75% Industry: -41,75%

GROSS MARGIN

82,73%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

22,17%

Sector: -41,04% Industry: -41,04%

P/EBITDA

13,65

Sector: -3,65 Industry: -3,65

P/EBIT

20,38

Sector: -3,64 Industry: -3,64

P/ASSET

2,35

Sector: 1,41 Industry: 1,41

BVPS

14,45

Sector: 1,84 Industry: 1,84

EPS

3,01

Sector: -2,20 Industry: -2,20

EQUITY / ASSETS

0,40

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

16,42%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

24,91%

Sector: - Industry: -

FAIR PRICE OF AstraZeneca ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 84,53

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-62,99%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

AZN indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,80	5,78	32,50%	2,69%	US$ 453,87 B	27,75%
PFE	16,92	1,75	10,33%	6,25%	US$ 155,60 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	16,20	10,21	62,99%	2,83%	US$ 265,17 B	34,74%
MRK	12,67	4,56	36,03%	3,59%	US$ 223,87 B	28,16%
BMY	17,97	5,29	29,44%	5,41%	US$ 92,49 B	10,71%
GILD	19,99	7,16	35,82%	2,79%	US$ 140,30 B	24,71%
ZTS	24,61	13,09	53,20%	1,32%	US$ 65,16 B	28,00%
HALO	14,26	25,08	175,93%	0,00%	US$ 8,35 B	48,21%
REGN	13,97	2,10	15,06%	0,44%	US$ 63,00 B	31,83%
AMGN	30,70	21,58	70,29%	3,15%	US$ 160,26 B	14,67%
VRTX	28,59	6,03	21,11%	0,00%	US$ 103,65 B	31,22%
MCK	24,89	-106,90	-429,55%	0,40%	US$ 92,26 B	0,97%
CAH	26,56	-13,96	-52,54%	1,31%	US$ 36,76 B	0,60%
ADMA	17,05	8,87	52,03%	0,00%	US$ 3,53 B	43,51%
BIIB	13,23	1,33	10,08%	0,00%	US$ 23,50 B	17,46%
HRMY	8,91	2,01	22,58%	0,00%	US$ 1,55 B	22,19%

comparison of AZN with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History AZN

current DY: 1,83%

5-year average DY: 2,52%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	08/08/2025	08/09/2025	0,51500000
Dividends	21/02/2025	24/03/2025	1,05000000
Dividends	09/08/2024	09/09/2024	0,50000000
Dividends	23/02/2024	25/03/2024	0,98500000
Dividends	11/08/2023	11/09/2023	0,46500000
Dividends	24/02/2023	27/03/2023	0,98500000
Dividends	12/08/2022	12/09/2022	0,46500000
Dividends	25/02/2022	28/03/2022	0,98500000
Dividends	13/08/2021	13/09/2021	0,45000000
Dividends	26/02/2021	29/03/2021	0,95000000
Dividends	14/08/2020	14/09/2020	0,45000000
Dividends	28/02/2020	30/03/2020	0,95000000
Dividends	09/08/2019	09/09/2019	0,45000000
Dividends	01/03/2019	27/03/2019	0,95000000
Dividends	10/08/2018	10/09/2018	0,45000000
Dividends	16/02/2018	19/03/2018	0,95000000
Dividends	11/08/2017	11/09/2017	0,45000000
Dividends	17/02/2017	20/03/2017	0,95000000
Dividends	12/08/2016	12/09/2016	0,45000000
Dividends	19/02/2016	21/03/2016	0,95000000
Dividends	14/08/2015	14/09/2015	0,45000000
Dividends	20/02/2015	23/03/2015	0,95000000
Dividends	15/08/2014	15/09/2014	0,45000000
Dividends	21/02/2014	24/03/2014	0,95000000
Dividends	16/08/2013	16/09/2013	0,45000000
Dividends	15/02/2013	18/03/2013	0,95000000
Dividends	10/08/2012	10/09/2012	0,45000000
Dividends	17/02/2012	19/03/2012	0,97500000
Dividends	08/08/2011	12/09/2011	0,42500000
Dividends	04/02/2011	14/03/2011	0,92500000
Dividends	06/08/2010	13/09/2010	0,35000000
Dividends	05/02/2010	15/03/2010	0,85500000
Dividends	07/08/2009	14/09/2009	0,29500000
Dividends	06/02/2009	16/03/2009	0,75000000
Dividends	08/08/2008	15/09/2008	0,27500000
Dividends	11/02/2008	17/03/2008	0,67500000
Dividends	10/08/2007	17/09/2007	0,26000000
Dividends	09/02/2007	19/03/2007	0,61500000
Dividends	11/08/2006	18/09/2006	0,24500000
Dividends	10/02/2006	20/03/2006	0,46000000
Dividends	12/08/2005	19/09/2005	0,19000000
Dividends	11/02/2005	21/03/2005	0,32250000
Dividends	13/08/2004	20/09/2004	0,14750000
Dividends	20/02/2004	06/04/2004	0,27000000
Dividends	22/08/2003	06/10/2003	0,12750000
Dividends	21/02/2003	07/04/2003	0,26100000
Dividends	23/08/2002	07/10/2002	0,12800000
Dividends	20/02/2002	08/04/2002	0,26100000
Dividends	22/08/2001	05/10/2001	0,12800000
Dividends	23/02/2001	09/04/2001	0,26100000
Dividends	08/09/2000	23/10/2000	0,12800000
Dividends	10/03/2000	17/04/2000	0,26100000
Dividends	10/09/1999	25/10/1999	0,12800000
Dividends	09/04/1999	28/04/1999	0,17500000

ABOUT THE COMPANY AstraZeneca

AstraZeneca PLC

Average user rating I10

4.0 (71 people)

Estados Unidos

33 years

Foundation: 1992

1993

Year of debut on the stock exchange - 32 years

74.800

Employees

Additional Information

The Company AstraZeneca PLC (Estados Unidos), is listed on Nasdaq with a market value of $ 264,46 Billions, having a net worth of $ 44,81 Billions.

With a total of 74.800 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 57,39 Billions, which generated a profit in the amount of $ 9,32 Billions.

As for its main indicators, the Company has a P/E ratio of 28,39, a P/BV ratio of 5,90 and in the last 12 months the dividend yield of AZN was at 1,83%.

The Company is traded internationally through the ticker AZN.

Market value

US$ 264,46 Billions

Net worth

US$ 44,81 Billions

US$ 44.810.000.000,00

Assets

US$ 112,42 Billions

US$ 112.422.000.000,00

Total Number of Shares

3,10 Billions

3.100.000.000

Average Daily Trading Volume

US$ 4,87 Milhões

US$ 4.873.207,10

Sector

Health Care

Industry

Biotechnology

AZN

AZN revenue and profits

AZN results

DRAG THE FRAME TO SEE MORE DATA

AZN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

BMY - Bristol-Myers Squibb

US$ 43,96 --10,61% (12M)

P/L

17,97

5,41%

ROE

29,44%

P/VP

5,29

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12 M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12 M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12 M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12 M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12 M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12 M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

BMY - Bristol-Myers Squibb

US$ 43,96 --10,61% (12 M)

P/L

17,97

5,41%

ROE

29,44%

P/VP

5,29

Frequently Asked Questions

What is the price of AstraZeneca (AZN) today?

The price of AstraZeneca (AZN) today is US$ 84,53, with a variation of 12.31% compared to the last year. The price of AstraZeneca (AZN) started the year trading around US$ 65,52 and today it is at US$ 84,53. Follow the real-time price chart, the historical price of AstraZeneca (AZN), and stock data from Ibovespa and international markets.

When does AstraZeneca (AZN) pay dividends?

AstraZeneca (AZN) distributed dividends in the last year,in the months of March and September totaling US$ 1,57. The Dividend Yield for the last 12 months is 1,83%.

AstraZeneca (AZN) is it worth it?

Currently, AstraZeneca (AZN) is priced at US$ 84,53, with a P/E of 28,39%, representing a deviation of 13,23% from its historical average P/E. In the last year, the stock showed a variation of 12.31% in its price and distributed US$ 1,57 in dividends, resulting in a Dividend Yield of 1,83%. The total shareholder return was 12,31%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of AstraZeneca (AZN)?

Investing in stocks of AstraZeneca (AZN) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of AstraZeneca (AZN) yield today?

The yield of AstraZeneca (AZN) was 4,60% in the last month, 12,31% in the last year and 71,62% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 1,57 in dividends, um Dividend Yield de 1,83%.

If you wanted to buy 100 stocks of AstraZeneca (AZN) today, the total investment would be US$ 8.453,00, based on the current price of US$ 84,53.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 9.493,56
In 5 years: US$ 14.507,04
In 10 years: 31.018,28

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AZN

AstraZeneca PLC

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of AZN

check out the fundamentals of AstraZeneca shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 1,83%

5-year average DY: 2,52%

type

date with

payment date

value

ABOUT THE COMPANY AstraZeneca

AstraZeneca PLC

Estados Unidos

33 years

1993

74.800

Additional Information

PROFIT X PRICE AZN

AZN results

AZN cash flow

evolution of assets - AZN

AZN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions